Philanthropy has always played a major role in research at UNC, but Barbara Dean has taken this one step further by being an active participant in supporting those research efforts. Dean’s experience ...

Grant terminations halt research on improving vaccinations and preventing future pandemics

WASHINGTON, D.C. – Today, U.S. Senators Tammy Baldwin (D-WI) and Peter Welch (D-VT) announced that...

Greater awareness, not vaccines, has driven an increase in diagnoses.

Rob Winn: Fighting for Better Access to Genetic Testing / AACI, Association of American Cancer Institutes, cancer, fight against cancer, genetic testing,

Dr. Francis Collins, a renowned geneticist, and former longtime director of the National Institutes of Health, is retiring from the government agency and urging “respect” for its embattled workers.

Administration officials pressured NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.

The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.

In the first month of the new administration responsible for leading the US, the executive branch has issued a flurry of orders, including ones associated with the dismissal or resignation of tens of ...

Directly contact your elected officials about the importance of cancer research, the need for continued funding and the latest lifesaving breakthroughs. In the United States, you can do so by sending ...

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD

Initial MRI showed asymptomatic brain lesions in 14% of patients, increasing to 25% at 6 months

This is a potentially devastating event — not just for the scientific community, but for all Americans.

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.

YouTube video by ONEST NETWORK

ASCO's CDK4/6 Inhibitor Dosing Knowledge (CDK) Study prioritizes patient advocacy and engagement to improve outcomes and quality of life for individuals with cancer.

By W. Kimryn Rathmell Director, National Cancer Institute Dr.

More than 11,000 researchers, clinicians, patient advocates and drugmakers gathered last week at the San Antonio Breast Cancer Symposium to share the latest treatments, tricks and tools to take down b...

In HER2+ early breast cancer (EBC), we investigated tumor and immune changes during neoadjuvant treatment and their impact on residual disease (RD) bi…

A team of researchers has received nearly $10 million in funding to develop the Cancer Identification and Precision Oncology Center.

Triple-negative breast cancer (TNBC) is a heterogenous disease with several molecular subtypes previously described. Here the authors perform a spatial transcriptomics analysis on a series of 92 patie...

Background To assess proportions of metastatic recurrence in women initially diagnosed with non-metastatic breast cancer by stage at diagnosis, breast cancer subtype, calendar period and age. Methods ...

Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin Forrest and colleagues1 conducted a d...

Friends Annual Meeting 2024 Recap: Sharing Next Steps and Opportunities with Advocates Thursday, December 5, 2024 12PM – 1PM ET Location: Virtual (Zoom) Webinar will also be streamed on YouTube Regist...